INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Sat, 4 Jul · 17:47 IST

Routine compliance filing - SEBI Regulation 74(5) certificate for Q1 FY27

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.0%1-day move
₹213.85
prior close
₹215.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.8+2.6+3.5+4.3+1.0+5.1+10.5+15.5+10.3+6.1+12.4
Up moveDown movePending
AI summary

Ind-Swift Laboratories filed a routine compliance certificate with the stock exchanges under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The certificate was issued by the company's Registrar and Share Transfer Agent, Alankit Assignments Limited, on 1 July 2026. It confirms that physical share certificates received for dematerialisation during the quarter were listed on the exchanges, verified, mutilated, and cancelled, with the depository recorded as the new registered owner. This is a standard procedural filing with no business or financial implications.

Likely market impact

Purely procedural compliance filing. No impact on shareholders, operations, or stock price.